Compare Zimmer Biomet Holdings Inc (ZBH) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Zimmer Biomet Holdings Inc vs Zoetis Inc — how do they compare? Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| ZBH | ZTS | |
|---|---|---|
Market Cap | $17.36B | $31.95B |
Sector | Health | Health |
52-Week High | $107.71 | $156.76 |
52-Week Low | $79.58 | $71.91 |
Enterprise Value | $24.40B | $39.24B |
Dividend Yield | 1.07% | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
